Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14901 - 14925 of 15119 in total
Experimental
Experimental
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Investigational
Displaying drugs 14901 - 14925 of 15119 in total